Background/Aims: In approximately 5% of chronic liver disease cases, no aet
iology can be identified. We selected sera from 50 patients with chronic he
patitis of unknown aetiology who were enrolled in this follow-up study whos
e aim is to gain insight into the possible role of viruses and to define po
tential clinical outcomes.
Methods: Patients' sera were screened with highly sensitive polymerase chai
n reaction assays for hepatitis B (HBV), C, D, and G viruses and TT virus.
Sera were also retested for antibodies against the core antigen of HBV.
Results: Surprisingly, HBV DNA was detected in both serum and liver in 15/5
0 (30%) patients. Immunostaining for HBV antigens on biopsies from patients
positive for HBV DNA showed HBcAg and/or HBsAg expression at low levels in
9/15 samples. Eleven of the fifteen patients were anti-HBc positive. With
one exception, all patients carried HBV genomes at low levels (10(4) copies
/ml or less), Histological signs of chronic liver disease were observed in
all patients.
Conclusion: Unrecognised HBV infections may account for a high proportion o
f chronic hepatitis cases of unknown aetiology, Improved HBV detection test
s, which appear mandatory for the diagnosis and management of non-A non-E h
epatitis as well as for improved safety of transfusions and transplantation
s are needed.
(C) 2001 European Association for the Study of the Liver. Published by Else
vier Science B,V, All rights reserved.